Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
BRAF-MEK-remming bij nieuw gediagnosticeerd papillair craniofaryngeoom
nov 2023 | Neuro-oncologie